DOPA in Parkinson's disease.
D000818:Animals; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008750:Methyldopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy
D008750:Methyldopa; D004295:Dihydroxyphenylalanine